serum prostate-specific antigen (psa) values Search Results


serum prostate specific antigen psa  (ALPCO)
93
ALPCO serum prostate specific antigen psa
A, Flow cytometric analysis depicting the lack of E4G10 binding to LnCap cells; J591, <t>mouse-anti</t> <t>prostate</t> specific membrane antigen is the positive control. Mouse and rat isotype controls were also evaluated. B, Photographs of in situ (left) and excised tumor (right) in a representative dual control and 225 Ac-E4G10 treated animal. C, Tumor volume in various treatment groups at described time-points. D, Serum prostate specific antigen <t>(PSA)</t> levels in the three treatment groups at 22 days post-implantation with 5 million LnCap cells. E, Kaplan Meier curve showing enhancement of survival with 225 Ac-E4G10 treatment. Data in C, D are mean ± S.E.M. Scale bar , 1 cm.
Serum Prostate Specific Antigen Psa, supplied by ALPCO, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/serum+prostate-specific+antigen+%28psa%29+values/pmc01801076-59-8-19?v=ALPCO
Average 93 stars, based on 1 article reviews
serum prostate specific antigen psa - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
serum prostate-specific antigen (psa) levels  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare serum prostate-specific antigen (psa) levels
A, Flow cytometric analysis depicting the lack of E4G10 binding to LnCap cells; J591, <t>mouse-anti</t> <t>prostate</t> specific membrane antigen is the positive control. Mouse and rat isotype controls were also evaluated. B, Photographs of in situ (left) and excised tumor (right) in a representative dual control and 225 Ac-E4G10 treated animal. C, Tumor volume in various treatment groups at described time-points. D, Serum prostate specific antigen <t>(PSA)</t> levels in the three treatment groups at 22 days post-implantation with 5 million LnCap cells. E, Kaplan Meier curve showing enhancement of survival with 225 Ac-E4G10 treatment. Data in C, D are mean ± S.E.M. Scale bar , 1 cm.
Serum Prostate Specific Antigen (Psa) Levels, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/serum+prostate-specific+antigen+%28psa%29+values/pmc03485445-44-15-26?v=Johns+Hopkins+HealthCare
Average 90 stars, based on 1 article reviews
serum prostate-specific antigen (psa) levels - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
serum prostate specific antigen levels  (Kadmon Pharmaceuticals)
90
Kadmon Pharmaceuticals serum prostate specific antigen levels
A, Flow cytometric analysis depicting the lack of E4G10 binding to LnCap cells; J591, <t>mouse-anti</t> <t>prostate</t> specific membrane antigen is the positive control. Mouse and rat isotype controls were also evaluated. B, Photographs of in situ (left) and excised tumor (right) in a representative dual control and 225 Ac-E4G10 treated animal. C, Tumor volume in various treatment groups at described time-points. D, Serum prostate specific antigen <t>(PSA)</t> levels in the three treatment groups at 22 days post-implantation with 5 million LnCap cells. E, Kaplan Meier curve showing enhancement of survival with 225 Ac-E4G10 treatment. Data in C, D are mean ± S.E.M. Scale bar , 1 cm.
Serum Prostate Specific Antigen Levels, supplied by Kadmon Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/serum+prostate-specific+antigen+%28psa%29+values/10__4172_slash_jbb__1000345-328-14-6?v=Kadmon+Pharmaceuticals
Average 90 stars, based on 1 article reviews
serum prostate specific antigen levels - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
prostate specific antigen (psa)  (College of American Pathologists)
90
College of American Pathologists prostate specific antigen (psa)
A, Flow cytometric analysis depicting the lack of E4G10 binding to LnCap cells; J591, <t>mouse-anti</t> <t>prostate</t> specific membrane antigen is the positive control. Mouse and rat isotype controls were also evaluated. B, Photographs of in situ (left) and excised tumor (right) in a representative dual control and 225 Ac-E4G10 treated animal. C, Tumor volume in various treatment groups at described time-points. D, Serum prostate specific antigen <t>(PSA)</t> levels in the three treatment groups at 22 days post-implantation with 5 million LnCap cells. E, Kaplan Meier curve showing enhancement of survival with 225 Ac-E4G10 treatment. Data in C, D are mean ± S.E.M. Scale bar , 1 cm.
Prostate Specific Antigen (Psa), supplied by College of American Pathologists, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/serum+prostate-specific+antigen+%28psa%29+values/10__1111_slash_j__1365___2559__2012__04359_26__x-456-37-18?v=College+of+American+Pathologists
Average 90 stars, based on 1 article reviews
prostate specific antigen (psa) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
prostate specific antigen antibody  (Thermo Fisher)
99
Thermo Fisher prostate specific antigen antibody
A, Flow cytometric analysis depicting the lack of E4G10 binding to LnCap cells; J591, <t>mouse-anti</t> <t>prostate</t> specific membrane antigen is the positive control. Mouse and rat isotype controls were also evaluated. B, Photographs of in situ (left) and excised tumor (right) in a representative dual control and 225 Ac-E4G10 treated animal. C, Tumor volume in various treatment groups at described time-points. D, Serum prostate specific antigen <t>(PSA)</t> levels in the three treatment groups at 22 days post-implantation with 5 million LnCap cells. E, Kaplan Meier curve showing enhancement of survival with 225 Ac-E4G10 treatment. Data in C, D are mean ± S.E.M. Scale bar , 1 cm.
Prostate Specific Antigen Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/serum+prostate-specific+antigen+%28psa%29+values/us08232584-1327-59-74?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
prostate specific antigen antibody - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
serum total prostate specific antigen tpsa activity  (Monobind)
94
Monobind serum total prostate specific antigen tpsa activity
A, Flow cytometric analysis depicting the lack of E4G10 binding to LnCap cells; J591, <t>mouse-anti</t> <t>prostate</t> specific membrane antigen is the positive control. Mouse and rat isotype controls were also evaluated. B, Photographs of in situ (left) and excised tumor (right) in a representative dual control and 225 Ac-E4G10 treated animal. C, Tumor volume in various treatment groups at described time-points. D, Serum prostate specific antigen <t>(PSA)</t> levels in the three treatment groups at 22 days post-implantation with 5 million LnCap cells. E, Kaplan Meier curve showing enhancement of survival with 225 Ac-E4G10 treatment. Data in C, D are mean ± S.E.M. Scale bar , 1 cm.
Serum Total Prostate Specific Antigen Tpsa Activity, supplied by Monobind, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/serum+prostate-specific+antigen+%28psa%29+values/10__9734_slash_ajrimps_slash_2025_slash_v14i4350-101-2-25?v=Monobind
Average 94 stars, based on 1 article reviews
serum total prostate specific antigen tpsa activity - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
serum prostate specific antigen psa  (Cusabio)
93
Cusabio serum prostate specific antigen psa
Low doses of TPL block the proliferation of CRPC cells in vitro . ( A ) LNCaP cells were treated with 6.25 nM TPL for 1 h before the addition of R1881 (1 nM) for 3 days. Cell viability was measured by MTT. ( B ) Number of colonies formed by CRPC cells (22Rv1 and C4-2) following incubation with different concentrations of TPL. ( C ) C4-2/Luci and C4-2/AR-V7 cells were treated with different concentrations of TPL for 4 days. Cell viability was measured by MTT. ( D ) Number of colonies formed by C4-2/Luci and C4-2/AR-V7 cells after treatment with TPL. ( E ) C4-2/Luci and C4-2/AR-V7 cells were cultured in 8% CSS 1640 medium for 24 h, followed by treatment with 6.25 nM TPL or 20 μM enzalutamide for 72 h. <t>PSA</t> was then detected <t>by</t> <t>ELISA.</t> The results are represented as means ±SD of 3 experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
Serum Prostate Specific Antigen Psa, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/serum+prostate-specific+antigen+%28psa%29+values/pmc05479278-72-3-16?v=Cusabio
Average 93 stars, based on 1 article reviews
serum prostate specific antigen psa - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
prostate specific antigen 2  (Rittenhouse Book Distributors)
86
Rittenhouse Book Distributors prostate specific antigen 2
Low doses of TPL block the proliferation of CRPC cells in vitro . ( A ) LNCaP cells were treated with 6.25 nM TPL for 1 h before the addition of R1881 (1 nM) for 3 days. Cell viability was measured by MTT. ( B ) Number of colonies formed by CRPC cells (22Rv1 and C4-2) following incubation with different concentrations of TPL. ( C ) C4-2/Luci and C4-2/AR-V7 cells were treated with different concentrations of TPL for 4 days. Cell viability was measured by MTT. ( D ) Number of colonies formed by C4-2/Luci and C4-2/AR-V7 cells after treatment with TPL. ( E ) C4-2/Luci and C4-2/AR-V7 cells were cultured in 8% CSS 1640 medium for 24 h, followed by treatment with 6.25 nM TPL or 20 μM enzalutamide for 72 h. <t>PSA</t> was then detected <t>by</t> <t>ELISA.</t> The results are represented as means ±SD of 3 experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
Prostate Specific Antigen 2, supplied by Rittenhouse Book Distributors, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/serum+prostate-specific+antigen+%28psa%29+values/pm23213079-278-33-4?v=Rittenhouse+Book+Distributors
Average 86 stars, based on 1 article reviews
prostate specific antigen 2 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
pathozyme prostate specific antigen ref 00 327  (Omega Diagnostics)
90
Omega Diagnostics pathozyme prostate specific antigen ref 00 327
Low doses of TPL block the proliferation of CRPC cells in vitro . ( A ) LNCaP cells were treated with 6.25 nM TPL for 1 h before the addition of R1881 (1 nM) for 3 days. Cell viability was measured by MTT. ( B ) Number of colonies formed by CRPC cells (22Rv1 and C4-2) following incubation with different concentrations of TPL. ( C ) C4-2/Luci and C4-2/AR-V7 cells were treated with different concentrations of TPL for 4 days. Cell viability was measured by MTT. ( D ) Number of colonies formed by C4-2/Luci and C4-2/AR-V7 cells after treatment with TPL. ( E ) C4-2/Luci and C4-2/AR-V7 cells were cultured in 8% CSS 1640 medium for 24 h, followed by treatment with 6.25 nM TPL or 20 μM enzalutamide for 72 h. <t>PSA</t> was then detected <t>by</t> <t>ELISA.</t> The results are represented as means ±SD of 3 experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
Pathozyme Prostate Specific Antigen Ref 00 327, supplied by Omega Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/serum+prostate-specific+antigen+%28psa%29+values/pm21644416-25-10-17?v=Omega+Diagnostics
Average 90 stars, based on 1 article reviews
pathozyme prostate specific antigen ref 00 327 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
prostate-specific antigen (psa)  (MyBiosource Biotechnology)
90
MyBiosource Biotechnology prostate-specific antigen (psa)
Low doses of TPL block the proliferation of CRPC cells in vitro . ( A ) LNCaP cells were treated with 6.25 nM TPL for 1 h before the addition of R1881 (1 nM) for 3 days. Cell viability was measured by MTT. ( B ) Number of colonies formed by CRPC cells (22Rv1 and C4-2) following incubation with different concentrations of TPL. ( C ) C4-2/Luci and C4-2/AR-V7 cells were treated with different concentrations of TPL for 4 days. Cell viability was measured by MTT. ( D ) Number of colonies formed by C4-2/Luci and C4-2/AR-V7 cells after treatment with TPL. ( E ) C4-2/Luci and C4-2/AR-V7 cells were cultured in 8% CSS 1640 medium for 24 h, followed by treatment with 6.25 nM TPL or 20 μM enzalutamide for 72 h. <t>PSA</t> was then detected <t>by</t> <t>ELISA.</t> The results are represented as means ±SD of 3 experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
Prostate Specific Antigen (Psa), supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/serum+prostate-specific+antigen+%28psa%29+values/pm39478652-93-0-22?v=MyBiosource+Biotechnology
Average 90 stars, based on 1 article reviews
prostate-specific antigen (psa) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
dimension vista® 500 intelligent lab system  (Siemens AG)
90
Siemens AG dimension vista® 500 intelligent lab system
Low doses of TPL block the proliferation of CRPC cells in vitro . ( A ) LNCaP cells were treated with 6.25 nM TPL for 1 h before the addition of R1881 (1 nM) for 3 days. Cell viability was measured by MTT. ( B ) Number of colonies formed by CRPC cells (22Rv1 and C4-2) following incubation with different concentrations of TPL. ( C ) C4-2/Luci and C4-2/AR-V7 cells were treated with different concentrations of TPL for 4 days. Cell viability was measured by MTT. ( D ) Number of colonies formed by C4-2/Luci and C4-2/AR-V7 cells after treatment with TPL. ( E ) C4-2/Luci and C4-2/AR-V7 cells were cultured in 8% CSS 1640 medium for 24 h, followed by treatment with 6.25 nM TPL or 20 μM enzalutamide for 72 h. <t>PSA</t> was then detected <t>by</t> <t>ELISA.</t> The results are represented as means ±SD of 3 experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
Dimension Vista® 500 Intelligent Lab System, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/serum+prostate-specific+antigen+%28psa%29+values/10__1093_slash_ajcp_slash_140__suppl1__200-10-2-1?v=Siemens+AG
Average 90 stars, based on 1 article reviews
dimension vista® 500 intelligent lab system - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
psa serum  (bioMerieux gmbh)
90
bioMerieux gmbh psa serum
Low doses of TPL block the proliferation of CRPC cells in vitro . ( A ) LNCaP cells were treated with 6.25 nM TPL for 1 h before the addition of R1881 (1 nM) for 3 days. Cell viability was measured by MTT. ( B ) Number of colonies formed by CRPC cells (22Rv1 and C4-2) following incubation with different concentrations of TPL. ( C ) C4-2/Luci and C4-2/AR-V7 cells were treated with different concentrations of TPL for 4 days. Cell viability was measured by MTT. ( D ) Number of colonies formed by C4-2/Luci and C4-2/AR-V7 cells after treatment with TPL. ( E ) C4-2/Luci and C4-2/AR-V7 cells were cultured in 8% CSS 1640 medium for 24 h, followed by treatment with 6.25 nM TPL or 20 μM enzalutamide for 72 h. <t>PSA</t> was then detected <t>by</t> <t>ELISA.</t> The results are represented as means ±SD of 3 experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
Psa Serum, supplied by bioMerieux gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/serum+prostate-specific+antigen+%28psa%29+values/10__32792_slash_utq_slash_utjsci_slash_v4i3__635-31-10-27?v=bioMerieux+gmbh
Average 90 stars, based on 1 article reviews
psa serum - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


A, Flow cytometric analysis depicting the lack of E4G10 binding to LnCap cells; J591, mouse-anti prostate specific membrane antigen is the positive control. Mouse and rat isotype controls were also evaluated. B, Photographs of in situ (left) and excised tumor (right) in a representative dual control and 225 Ac-E4G10 treated animal. C, Tumor volume in various treatment groups at described time-points. D, Serum prostate specific antigen (PSA) levels in the three treatment groups at 22 days post-implantation with 5 million LnCap cells. E, Kaplan Meier curve showing enhancement of survival with 225 Ac-E4G10 treatment. Data in C, D are mean ± S.E.M. Scale bar , 1 cm.

Journal: PLoS ONE

Article Title: Selective Alpha-Particle Mediated Depletion of Tumor Vasculature with Vascular Normalization

doi: 10.1371/journal.pone.0000267

Figure Lengend Snippet: A, Flow cytometric analysis depicting the lack of E4G10 binding to LnCap cells; J591, mouse-anti prostate specific membrane antigen is the positive control. Mouse and rat isotype controls were also evaluated. B, Photographs of in situ (left) and excised tumor (right) in a representative dual control and 225 Ac-E4G10 treated animal. C, Tumor volume in various treatment groups at described time-points. D, Serum prostate specific antigen (PSA) levels in the three treatment groups at 22 days post-implantation with 5 million LnCap cells. E, Kaplan Meier curve showing enhancement of survival with 225 Ac-E4G10 treatment. Data in C, D are mean ± S.E.M. Scale bar , 1 cm.

Article Snippet: Mice were bled retro-orbitally on described days and serum prostate specific antigen (PSA) was determined using an immunoassay kit (Alpco diagnostics, Windham, NH).

Techniques: Binding Assay, Membrane, Positive Control, In Situ, Control

Low doses of TPL block the proliferation of CRPC cells in vitro . ( A ) LNCaP cells were treated with 6.25 nM TPL for 1 h before the addition of R1881 (1 nM) for 3 days. Cell viability was measured by MTT. ( B ) Number of colonies formed by CRPC cells (22Rv1 and C4-2) following incubation with different concentrations of TPL. ( C ) C4-2/Luci and C4-2/AR-V7 cells were treated with different concentrations of TPL for 4 days. Cell viability was measured by MTT. ( D ) Number of colonies formed by C4-2/Luci and C4-2/AR-V7 cells after treatment with TPL. ( E ) C4-2/Luci and C4-2/AR-V7 cells were cultured in 8% CSS 1640 medium for 24 h, followed by treatment with 6.25 nM TPL or 20 μM enzalutamide for 72 h. PSA was then detected by ELISA. The results are represented as means ±SD of 3 experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.001.

Journal: Theranostics

Article Title: Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells

doi: 10.7150/thno.17852

Figure Lengend Snippet: Low doses of TPL block the proliferation of CRPC cells in vitro . ( A ) LNCaP cells were treated with 6.25 nM TPL for 1 h before the addition of R1881 (1 nM) for 3 days. Cell viability was measured by MTT. ( B ) Number of colonies formed by CRPC cells (22Rv1 and C4-2) following incubation with different concentrations of TPL. ( C ) C4-2/Luci and C4-2/AR-V7 cells were treated with different concentrations of TPL for 4 days. Cell viability was measured by MTT. ( D ) Number of colonies formed by C4-2/Luci and C4-2/AR-V7 cells after treatment with TPL. ( E ) C4-2/Luci and C4-2/AR-V7 cells were cultured in 8% CSS 1640 medium for 24 h, followed by treatment with 6.25 nM TPL or 20 μM enzalutamide for 72 h. PSA was then detected by ELISA. The results are represented as means ±SD of 3 experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.001.

Article Snippet: The level of serum prostate specific antigen (PSA) in mouse blood was determined using quantitative ELISA (Cusabio Biotech.

Techniques: Blocking Assay, In Vitro, Incubation, Cell Culture, Enzyme-linked Immunosorbent Assay